Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.
暂无分享,去创建一个
David G. Morris | R. Heller | N. Kaminski | D. Sheppard | J. Allard | J. Pittet | F. Zuo | M. Griffiths | X. Huang
[1] Andrius Kazlauskas,et al. Diverse Signaling Pathways Activated by Growth Factor Receptors Induce Broadly Overlapping, Rather Than Independent, Sets of Genes , 1999, Cell.
[2] L. Kobzik,et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. , 1999, The Journal of clinical investigation.
[3] D. Denhardt,et al. Osteopontin Function in Pathology: Lessons from Osteopontin-Deficient Mice , 1999, Nephron Experimental Nephrology.
[4] N. Kaminski,et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.
[5] C. Chresta,et al. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop , 1999, Oncogene.
[6] B. Williams,et al. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .
[7] M. Lindstrom,et al. Heterogeneous expression of the lipocalin NGAL in primary breast cancers , 1998, International journal of cancer.
[8] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] Talmadge E. King Jr.,et al. Update in Pulmonary Medicine , 1998, Annals of Internal Medicine.
[10] T. Hartman,et al. Idiopathic pulmonary fibrosis: current concepts. , 1998, Mayo Clinic proceedings.
[11] B. Hogan,et al. Altered wound healing in mice lacking a functional osteopontin gene (spp1). , 1998, The Journal of clinical investigation.
[12] R. Swiderski,et al. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. , 1998, The American journal of pathology.
[13] L. Wodicka,et al. Genome-wide expression monitoring in Saccharomyces cerevisiae , 1997, Nature Biotechnology.
[14] M. Haase,et al. Cellular distribution of c-Jun and c-Fos in rat lung before and after bleomycin induced injury , 1997, Virchows Archiv.
[15] D. Meek,et al. Modifications of p53 protein and accumulation of p21 and gadd45 mRNA in TGF-beta 1 growth inhibited cells. , 1997, Cellular signalling.
[16] B. Nielsen,et al. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. , 1996, Gut.
[17] D. Sheppard,et al. A point mutation in the integrin beta 6 subunit abolishes both alpha v beta 6 binding to fibronectin and receptor localization to focal contacts. , 1995, American journal of respiratory cell and molecular biology.
[18] R. McAnulty,et al. Increased type I procollagen mRNA transcripts in the lungs of mice during the development of bleomycin-induced fibrosis. , 1994, The European respiratory journal.
[19] W. Black,et al. The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.
[20] H. Sengeløv,et al. Molecular cloning and expression of a cDNA encoding NGAL: a lipocalin expressed in human neutrophils. , 1994, Biochemical and biophysical research communications.
[21] R. Locksley,et al. Constructing polycompetitor cDNAs for quantitative PCR (J. Immunol. Methods 165 (1993) 37-46). , 1994, Journal of immunological methods.
[22] B. de Crombrugghe,et al. Enhanced type III collagen gene expression during bleomycin induced lung fibrosis. , 1993, Thorax.
[23] T. Ley,et al. Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. , 1992, The Journal of biological chemistry.
[24] C. Haslett,et al. The intensity of chronic lung inflammation and fibrosis after bleomycin is directly related to the severity of acute injury. , 1988, The American review of respiratory disease.
[25] M. Kris,et al. Bronchoalveolar lavage cell populations in bleomycin lung toxicity. , 1987, Thorax.
[26] D. Hyde,et al. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. , 1983, The American journal of pathology.
[27] G. Snider,et al. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin: pathology and stereology. , 1978, The American review of respiratory disease.
[28] Robert V Farese,et al. Inactivation of the Integrin [36 Subunit Gene Reveals a Role of Epithelial Integrins in Regulating Inflammation in the Lungs and Skin , 2002 .
[29] W. Leonard,et al. Jaks and STATs: biological implications. , 1998, Annual review of immunology.
[30] W. El-Deiry,et al. Regulation of p53 downstream genes. , 1998, Seminars in cancer biology.
[31] U. Boehm,et al. Cellular responses to interferon-gamma. , 1997, Annual review of immunology.
[32] G. Snider,et al. Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[33] R. D. McCoy,et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. , 1996, The Journal of clinical investigation.